Richard Treagus – Executive Chairman, BTC health
Dr. Treagus is a physician and entrepreneur with over 20 years’ experience in all aspects of the international pharmaceutical and biotechnology industry. Richard served as Chief Executive of ASX-listed company Acrux (ASX Code: ACR) until 2012, and is currently the Executive Chairman of Neuren Pharmaceuticals Limited (ASX Code: NEU).
Oskar Hakansson – Business Development Director, BTC health
Oskar has over 25 years’ experience in the pharmaceutical industry having worked for both large and small companies and with management experience in sales, marketing, acquisitions, pipeline development and product sourcing.
Stuart Jones – Company Secretary
Mr. Jones is a Chartered Accountant, Company Secretary and a Director of an Accountancy and Financial Planning practice. Stuart is an active investor in public companies in the biotech and life sciences sector.
Cameron Jones – Managing Director, Bio101
Cameron provides financial services to the life science industry. Cameron acts as CFO and Company Secretary for a number of ASX listed life science companies.
Amy Choi – Business Unit Manager, BTC Speciality Health
Amy Choi is a PhD qualified Pharmacist with extensive experience in sales, marketing and business development across the Pharmaceutical, Medical Devices and Biotechnology industries in ANZ and Asia Pacific markets. She was formerly Head of Commercial Operations, Mallinckrodt Pharmaceuticals (Australia) and prior to that, APAC Commercial manager at Hospira (now Pfizer Inc).